These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31694423)

  • 1. Chronic Hepatitis C Infection Has No Effect on Peripheral CD4
    Hassuna NA; Mansour M; Ahmed TI; Hassan EA; Hefzy MM; Abd Elghani WM; Hefzy EM
    Immunol Invest; 2020 May; 49(4):477-488. PubMed ID: 31694423
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased peripheral CD4
    Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
    J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hemodialysis on circulating CD4(low)CD25 (high) regulatory T cells in end-stage renal disease patients.
    Lisowska KA; Dębska-Ślizień A; Jasiulewicz A; Bryl E; Witkowski JM
    Inflamm Res; 2014 Feb; 63(2):99-103. PubMed ID: 24189710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End stage renal disease has an early and continuous detrimental effect on regulatory T cells.
    Sampani E; Vagiotas L; Daikidou DV; Nikolaidou V; Xochelli A; Kasimatis E; Lioulios G; Dimitriadis C; Fylaktou A; Papagianni A; Stangou M
    Nephrology (Carlton); 2022 Mar; 27(3):281-287. PubMed ID: 34781412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic features of innate and adaptive immunity in patients with chronic hepatitis C and end-stage renal disease.
    Barbosa KV; Teixeira R; Bassetti-Soares E; de Souza AF; Penido JM; Teixeira-Carvalho A; Martins-Filho OA
    Liver Int; 2013 Oct; 33(9):1349-56. PubMed ID: 23692646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
    Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
    Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28null and Regulatory T Cells Are Substantially Disrupted in Patients with End-Stage Renal Disease Due to Diabetes Mellitus.
    Sampani E; Daikidou DV; Lioulios G; Xochelli A; Mitsoglou Z; Nikolaidou V; Dimitriadis C; Fylaktou A; Papagianni A; Stangou M
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased CD4
    Wei K; Jiang BC; Guan JH; Zhang DN; Zhang MX; Wu JL; Zhu GZ
    Viral Immunol; 2018 Oct; 31(8):559-567. PubMed ID: 30067145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4⁺ and CD8⁺ regulatory T cells (Tregs) are elevated and display an active phenotype in patients with chronic HCV mono-infection and HIV/HCV co-infection.
    Hartling HJ; Gaardbo JC; Ronit A; Knudsen LS; Ullum H; Vainer B; Clausen MR; Skogstrand K; Gerstoft J; Nielsen SD
    Scand J Immunol; 2012 Sep; 76(3):294-305. PubMed ID: 22671952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.
    Dolganiuc A; Paek E; Kodys K; Thomas J; Szabo G
    Gastroenterology; 2008 Dec; 135(6):2119-27. PubMed ID: 18835391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of peripheral blood natural killer cells, T-cell helper/T-cell suppressor ratio and intercurrent infection frequency in hepatitis C seropositive prevalent hemodialysis patients.
    Ibrahim MA; Mostafa AA; El-Said HW; Mohab AM; Hebah HA
    Hemodial Int; 2014 Oct; 18 Suppl 1():S23-31. PubMed ID: 25330828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.
    Boettler T; Spangenberg HC; Neumann-Haefelin C; Panther E; Urbani S; Ferrari C; Blum HE; von Weizsäcker F; Thimme R
    J Virol; 2005 Jun; 79(12):7860-7. PubMed ID: 15919940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining target antigens for CD25+ FOXP3 + IFN-gamma- regulatory T cells in chronic hepatitis C virus infection.
    Li S; Jones KL; Woollard DJ; Dromey J; Paukovics G; Plebanski M; Gowans EJ
    Immunol Cell Biol; 2007; 85(3):197-204. PubMed ID: 17199111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients].
    Zhang HH; Fei R; Mei MH; Liao WJ; Wang XY; Cong X; Qin LL; Ji Y; Wang SX; Wei L; Chen HS
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):266-72. PubMed ID: 17456313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C.
    Wang JP; Zhang Y; Wei X; Li J; Nan XP; Yu HT; Li Y; Wang PZ; Bai XF
    APMIS; 2010 Apr; 118(4):261-70. PubMed ID: 20402671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of CD4+ CD25+ FoxP3+ regulatory T cells in chronic hepatitis C virus infection.
    Hashempoor T; Bamdad T; Merat S; Janzamin E; Nemati L; Jabbari H; Sharifi AH; Zamini H
    Iran J Immunol; 2010 Sep; 7(3):177-85. PubMed ID: 20876988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.
    Yin M; Zhang J; Wang Y; Wang S; Böckler D; Duan Z; Xin S
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1825-31. PubMed ID: 20448211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated frequency and function of regulatory T cells in patients with active chronic hepatitis C.
    Tseng KC; Ho YC; Hsieh YH; Lai NS; Wen ZH; Li C; Wu SF
    J Gastroenterol; 2012 Jul; 47(7):823-33. PubMed ID: 22367277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells.
    Hendrikx TK; van Gurp EA; Mol WM; Schoordijk W; Sewgobind VD; Ijzermans JN; Weimar W; Baan CC
    Nephrol Dial Transplant; 2009 Jun; 24(6):1969-78. PubMed ID: 19193737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4(+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatment.
    Soldevila B; Alonso N; Martínez-Arconada MJ; Morillas RM; Planas R; Sanmartí AM; Martínez-Cáceres EM
    J Viral Hepat; 2011 Jun; 18(6):384-92. PubMed ID: 20487258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.